How Much Did Microdermics Raise?
Funding & Key Investors

Microdermics has successfully secured a major strategic investment, marking a pivotal milestone in its mission to modernize the biopharmaceutical landscape. With a total capital accumulation of $1M, the firm is well-positioned to accelerate the commercialization of its proprietary microneedle injection system. This recent funding round, totaling $1M, underscores the market confidence in the company's ability to disrupt the traditional hypodermic needle paradigm within the expansive $800 billion global biotherapeutics sector.

The infusion of capital serves as a critical catalyst for scaling operations and refining the manufacturing processes required for mass-market adoption. By prioritizing patient comfort and delivery efficiency, Microdermics is effectively positioning itself as a leader in the next generation of drug administration technologies.